Vascular Biogenics Ltd (VBLT)

[Oren1976]

Worrying about globe trial. There are some signs received feedback a while ago the trial is not doing well even 3 signs. First sign was changing the trigger for interim and final. Second sign is refusing the spa. Probably vblt wanted to do a similar to ph2 globe trial with people starting only on vb112 and only later move to avastin but fda refused and they blame the fda and spa for the globe results they heard ... From seeing how this CEO thinks I still believe it will be a success because this CEO is always in fear of failing and I think he himself is too worried about the trial and vb111 although combined with avastin that disturb vb111 by provoking the cancer or by killing the nicer sells leaving vb111 with provoked more aggressive cancer. Even with it on his back I believe vb111 will win but it looks scary.